AC
GH icon

AXQ Capital’s Guardant Health GH Stock Holding History

AXQ Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,800
Closed -$202K – 710
2023
Q3 		$202K Buy
+6,800
New +$239K 0.07% 391
2023
Q1 		– Sell
-10,884
Closed -$296K – 537
2022
Q4 		$296K Buy
+10,884
New +$498K 0.21% 191

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AXQ Capital's GH Position: Q4 2023 in Review

AXQ Capital sold out of Guardant Health (GH) in Q4 2023, closing a stake of 6,800 shares — an estimated $202K sold.

AXQ Capital first reported a position in GH in Q4 2022 and held it in 2 quarters. The position peaked at $296K in Q4 2022. 295 funds tracked by Wall St. Rank hold GH as of Q4 2023.

  • AXQ Capital reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
  • AXQ Capital sold 6,800 Guardant Health shares in Q4 2023, an estimated $202K.
  • AXQ Capital first reported a position in Guardant Health in Q4 2022 and held it in 2 quarters.
  • AXQ Capital's Guardant Health position peaked at $296K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on AXQ Capital's 13F filing for Q4 2023, filed 13 Feb 2024.